Kuros Biosciences AG KURN.SW Stock
Kuros Biosciences AG Price Chart
Kuros Biosciences AG KURN.SW Financial and Trading Overview
| Kuros Biosciences AG stock price | 7.81 CHF |
| Previous Close | 1.28 CHF |
| Open | 1.33 CHF |
| Bid | 1.3 CHF x 0 |
| Ask | 1.33 CHF x 0 |
| Day's Range | 1.33 - 1.33 CHF |
| 52 Week Range | 1.11 - 2.08 CHF |
| Volume | 1K CHF |
| Avg. Volume | 23.39K CHF |
| Market Cap | 48.6M CHF |
| Beta (5Y Monthly) | 0.7659 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.38 CHF |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.05 CHF |
KURN.SW Valuation Measures
| Enterprise Value | 26.7M CHF |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.7023048 |
| Price/Book (mrq) | 0.70594484 |
| Enterprise Value/Revenue | 1.485 |
| Enterprise Value/EBITDA | -2.406 |
Trading Information
Kuros Biosciences AG Stock Price History
| Beta (5Y Monthly) | 0.7659 |
| 52-Week Change | -29.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.08 CHF |
| 52 Week Low | 1.11 CHF |
| 50-Day Moving Average | 1.32 CHF |
| 200-Day Moving Average | 1.51 CHF |
KURN.SW Share Statistics
| Avg. Volume (3 month) | 23.39K CHF |
| Avg. Daily Volume (10-Days) | 10.76K CHF |
| Shares Outstanding | 36.54M |
| Float | 23.58M |
| Short Ratio | N/A |
| % Held by Insiders | 39.36% |
| % Held by Institutions | 12.86% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -81.14% |
| Operating Margin (ttm) | -74.75% |
| Gross Margin | 30.99% |
| EBITDA Margin | -61.71% |
Management Effectiveness
| Return on Assets (ttm) | -9.64% |
| Return on Equity (ttm) | -20.016% |
Income Statement
| Revenue (ttm) | 17.99M CHF |
| Revenue Per Share (ttm) | 0.53 CHF |
| Quarterly Revenue Growth (yoy) | 59.89% |
| Gross Profit (ttm) | 5.58M CHF |
| EBITDA | -11100000 CHF |
| Net Income Avi to Common (ttm) | -14595000 CHF |
| Diluted EPS (ttm) | -0.42 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 24.07M CHF |
| Total Cash Per Share (mrq) | 0.66 CHF |
| Total Debt (mrq) | 1.98M CHF |
| Total Debt/Equity (mrq) | 2.88 CHF |
| Current Ratio (mrq) | 2.494 |
| Book Value Per Share (mrq) | 1.884 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7348000 CHF |
| Levered Free Cash Flow (ttm) | -6796750 CHF |
Profile of Kuros Biosciences AG
| Country | Switzerland |
| State | N/A |
| City | Schlieren |
| Address | Wagistrasse 25 |
| ZIP | 8952 |
| Phone | 41 44 733 4747 |
| Website | https://www.kuros.ch |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 66 |
Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical products for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through three segments: Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company's orthobiologics pipeline products include MagnetOs Granules, MagnetOs Putty, MagnetOs Easypack Putty, and MagnetOs Flex Matrix in EU and US for the treatment of orthopedics, spinal, and dental problems. Its Fibrin-PTH orthobiologics pipeline products comprise KUR-111, which has completed Phase 2b clinical trial for the treatment of tibial plateau fractures; and KUR-113, which completed Phase 2b clinical trial for the treatment of tibial shaft fractures, as well as is in the Phase II trial for the treatment of spinal interbody fusion. The company's sealants pipeline products include Neuroseal EU and US, synthetic tissue sealant for the prevention of cerebrospinal fluid leakage following cranial or spinal surgery. It has collaboration with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.
Q&A For Kuros Biosciences AG Stock
What is a current KURN.SW stock price?
Kuros Biosciences AG KURN.SW stock price today per share is 7.81 CHF.
How to purchase Kuros Biosciences AG stock?
You can buy KURN.SW shares on the Swiss exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kuros Biosciences AG?
The stock symbol or ticker of Kuros Biosciences AG is KURN.SW.
Which industry does the Kuros Biosciences AG company belong to?
The Kuros Biosciences AG industry is Medical Devices.
How many shares does Kuros Biosciences AG have in circulation?
The max supply of Kuros Biosciences AG shares is 36.82M.
What is Kuros Biosciences AG Price to Earnings Ratio (PE Ratio)?
Kuros Biosciences AG PE Ratio is now.
What was Kuros Biosciences AG earnings per share over the trailing 12 months (TTM)?
Kuros Biosciences AG EPS is -0.38 CHF over the trailing 12 months.
Which sector does the Kuros Biosciences AG company belong to?
The Kuros Biosciences AG sector is Healthcare.
Kuros Biosciences AG KURN.SW included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| SPI TR SSHI | 15051.28 CHF 17125.13 USD |
-0.5
|
— — | 15030.9 CHF 17101.95 USD | 15256.93 CHF 17359.12 USD | — - | — — |
- {{ link.label }} {{link}}